If the novel factor XI inhibitor abelacimab reaches the market for patients with atrial fibrillation (AF) who require anticoagulation, it may not be necessary to interrupt treatment ahead of invasive ...
Public News Service on MSN
In hemophiliac patients have innovative treatment option
Hemophilia, a genetic bleeding disorder that prevents the body from clotting blood, can turn a simple paper cut into a deadly bleeding episode. But Indiana residents suffering from the disease now ...
JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Patients with recent use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDS), or anti-clotting drugs such as clopidogreal (Plavix) do not appear to have an ...
A clinical decision support tool helped physicians identify patients at high risk of bleeding complications prior to undergoing a coronary intervention procedure and helped guide the use of bleeding ...
Hyloris Pharmaceuticals has enrolled the first patient in a phase III trial for its oral rinse that controls bleeding during and after procedures in dental patients who are taking anticoagulants.
Experts estimate that 20 percent of women experience excessive or prolonged menstrual bleeding at some time during their lives, particularly as they approach menopause. A new, less invasive procedure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results